Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials
Titel:
Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials
Auteur:
Maurer, M.J. Habermann, T.M. Shi, Q. Schmitz, N. Cunningham, D. Pfreundschuh, M. Seymour, J.F. Jaeger, U. Haioun, C. Tilly, H. Ghesquieres, H. Merli, F. Ziepert, M. Herbrecht, R. Flament, J. Fu, T. Flowers, C.R. Coiffier, B.